Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
USUN Bio is a Chinese biomaterials and medical device company focused on translating mussel adhesive protein into healthcare products and functional biomaterials. Founded in 2011, the company develops, manufactures, and commercializes wound-care dressings, liquid dressings, hydrogels, and related products based on mussel adhesive protein and biomimetic protein materials. The company positions itself as a pioneer in medical applications of mussel adhesive protein, with capabilities spanning raw-material purification, formulation, device development, registration, and commercialization. In addition to finished medical products, USUN Bio supplies functional biomaterial ingredients and supports cosmetics and healthcare applications. Its operations include production facilities in Jiangyin, Jiangsu and Guanghan, Sichuan, as well as R&D activities in Shanghai and Sweden.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on USUN Bio.